Views & Analysis How digital is reversing fortunes in R&D A new report lays out the ways digital transformation could reverse the trend of declining ROI in pharma R&D.
Views & Analysis Roche, big data and patient outcomes: the pharmaphorum podca... In the first pharmaphorum podcast of 2020 Roche’s Conor Megaw talks about his company’s approach to big data and how some of its partnerships have been performing.
News Novartis taps Microsoft’s AI expertise for drug development Novartis has forged an alliance with Microsoft that will apply artificial intelligence and machine-learning to the discovery
Views & Analysis The top 10 ways digital will transform healthcare Janssen’s Kris Sterkens gives his thoughts on how digital will continue to influence healthcare in the age of information.
Digital Company profile: Evidera Data disruption and applying ‘enabled intelligence’ to convert the promise shown in clinical trials into real-world success.
News FDA finally okays Novavax's COVID-19 jab, with restrictions The FDA has granted full approval to Novavax's COVID-19 vaccine after a delay, but has limited its use.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
